News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Senior Merck & Co., Inc. Executive to Head International AIDS Vaccine Initiative’s AIDS Vaccine Design and Development Laboratory
August 10, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK--(BUSINESS WIRE)--The International AIDS Vaccine Initiative (IAVI) is pleased to announce the appointment of Michael Caulfield as Executive Director of the IAVI AIDS Vaccine Design and Development Laboratory (DDL).
Twitter
LinkedIn
Facebook
Email
Print
People
Merck & Co.
MORE ON THIS TOPIC
Insights
From Sound Bites to Signals: Editors Parse Executive and Investor Chatter at JPM
January 22, 2026
·
1 min read
·
Jennifer Smith-Parker
Insights
The New Gold Rush in Brain Science
January 22, 2026
·
5 min read
·
Jennifer Smith-Parker
Earnings
J&J Aims for $100B in Sales, Puts Stelara Patent Cliff ‘in the Rearview Mirror’
January 21, 2026
·
2 min read
·
Dan Samorodnitsky
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
January 21, 2026
·
1 min read
·
Heather McKenzie